Baidu
map

风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2021 SIR临床实践指南：纤维肌痛的诊断和治疗

2021-08-03 意大利风湿病学学会 Reumatismo

纤维肌痛

2021年8月，意大利风湿病学学会(SIR)发布了纤维肌痛的诊断和治疗指南。纤维肌痛和纤维肌痛综合征（FMS）是一种中枢致敏综合征，主要表现为肌肉骨骼疼痛及多种伴随症状。

中文标题：

2021 SIR临床实践指南：纤维肌痛的诊断和治疗

英文标题：

The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence

发布机构：

意大利风湿病学学会

发布日期：

2021-08-03

简要介绍：

2021年8月，意大利风湿病学学会(SIR)发布了纤维肌痛的诊断和治疗指南。纤维肌痛和纤维肌痛综合征（FMS）是一种中枢致敏综合征，主要表现为肌肉骨骼疼痛及多种伴随症状。本文主要针对纤维肌痛和维肌痛综合征（FMS）的诊断和治疗提供循证指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=1362-Article Text-5920-1-10-20210803.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a871a1c002210eb8, title=2021 SIR临床实践指南：纤维肌痛的诊断和治疗, enTitle=The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence, guiderFrom=Reumatismo, authorId=0, author=, summary=2021年8月，意大利风湿病学学会(SIR)发布了纤维肌痛的诊断和治疗指南。纤维肌痛和纤维肌痛综合征（FMS）是一种中枢致敏综合征，主要表现为肌肉骨骼疼痛及多种伴随症状。, cover=https://img.medsci.cn/20211016/1634368418692_1608702.jpg, journalId=0, articlesId=null, associationId=1454, associationName=意大利风湿病学学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 03 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，意大利风湿病学学会(SIR)发布了纤维肌痛的诊断和治疗指南。纤维肌痛和纤维肌痛综合征（FMS）是一种中枢致敏综合征，主要表现为肌肉骨骼疼痛及多种伴随症状。本文主要针对纤维肌痛和维肌痛综合征（FMS）的诊断和治疗提供循证指导建议。</span></p>, tagList=[TagDto(tagId=9309, tagName=纤维肌痛)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7159, guiderKeyword=纤维肌痛治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3807, appHits=121, showAppHits=0, pcHits=628, showPcHits=3685, likes=2, shares=5, comments=9, approvalStatus=1, publishedTime=Sun Oct 17 22:15:30 CST 2021, publishedTimeString=2021-08-03, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sun Oct 17 21:32:39 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:16:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1362-Article Text-5920-1-10-20210803.pdf)])
1362-Article Text-5920-1-10-20210803.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1212657, encodeId=7b30121265eea, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:42:13 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082120, encodeId=46f5108212010, content=不错子 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:12:33 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082123, encodeId=06e11082123ee, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:14:59 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081275, encodeId=3cf610812e59e, content=下载学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17326410074, createdName=ms4000001579474341, createdTime=Fri Dec 17 20:49:19 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067134, encodeId=8827106e1346a, content=正在找这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200712/6f9852824ff74cb7b41bfadc6def725a/17f888abd46b45298c63c1e99f20b053.jpg, createdBy=26db2301884, createdName=ad70000, createdTime=Fri Nov 05 06:05:42 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2022-04-19 qqnded

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1212657, encodeId=7b30121265eea, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:42:13 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082120, encodeId=46f5108212010, content=不错子 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:12:33 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082123, encodeId=06e11082123ee, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:14:59 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081275, encodeId=3cf610812e59e, content=下载学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17326410074, createdName=ms4000001579474341, createdTime=Fri Dec 17 20:49:19 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067134, encodeId=8827106e1346a, content=正在找这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200712/6f9852824ff74cb7b41bfadc6def725a/17f888abd46b45298c63c1e99f20b053.jpg, createdBy=26db2301884, createdName=ad70000, createdTime=Fri Nov 05 06:05:42 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-12-20 ms6000002125076857

    不错子

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1212657, encodeId=7b30121265eea, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:42:13 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082120, encodeId=46f5108212010, content=不错子 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:12:33 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082123, encodeId=06e11082123ee, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:14:59 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081275, encodeId=3cf610812e59e, content=下载学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17326410074, createdName=ms4000001579474341, createdTime=Fri Dec 17 20:49:19 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067134, encodeId=8827106e1346a, content=正在找这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200712/6f9852824ff74cb7b41bfadc6def725a/17f888abd46b45298c63c1e99f20b053.jpg, createdBy=26db2301884, createdName=ad70000, createdTime=Fri Nov 05 06:05:42 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-12-20 ms6000002125076857

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1212657, encodeId=7b30121265eea, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:42:13 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082120, encodeId=46f5108212010, content=不错子 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:12:33 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082123, encodeId=06e11082123ee, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:14:59 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081275, encodeId=3cf610812e59e, content=下载学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17326410074, createdName=ms4000001579474341, createdTime=Fri Dec 17 20:49:19 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067134, encodeId=8827106e1346a, content=正在找这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200712/6f9852824ff74cb7b41bfadc6def725a/17f888abd46b45298c63c1e99f20b053.jpg, createdBy=26db2301884, createdName=ad70000, createdTime=Fri Nov 05 06:05:42 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-12-17 ms4000001579474341

    下载学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1212657, encodeId=7b30121265eea, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc292854358, createdName=qqnded, createdTime=Tue Apr 19 20:42:13 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082120, encodeId=46f5108212010, content=不错子 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:12:33 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082123, encodeId=06e11082123ee, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68fd6414252, createdName=ms6000002125076857, createdTime=Mon Dec 20 16:14:59 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081275, encodeId=3cf610812e59e, content=下载学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17326410074, createdName=ms4000001579474341, createdTime=Fri Dec 17 20:49:19 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067134, encodeId=8827106e1346a, content=正在找这个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200712/6f9852824ff74cb7b41bfadc6def725a/17f888abd46b45298c63c1e99f20b053.jpg, createdBy=26db2301884, createdName=ad70000, createdTime=Fri Nov 05 06:05:42 CST 2021, time=2021-11-05, status=1, ipAttribution=)]
    2021-11-05 ad70000

    正在找这个

    0

相关指南

2016 EULAR修订建议：纤维肌痛的管理

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2016-07-04

2011 纤维肌痛综合征诊断和治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2011-08-01

Baidu
map
Baidu
map
Baidu
map